Navigation Links
BioReference Laboratories Partners With Sysmex America
Date:4/16/2009

a part of their growth as the company continues to lay the groundwork for a sustainable future," said John Kershaw, President, Sysmex America, Inc.

BioReference Laboratories' Sysmex Intelligent Automation Solution enables hands-free hematology testing, slide making and staining, sorting, archiving, repeat testing and decision processes; while achieving the highest throughputs within one of the industry's smallest footprints. BioReference also will benefit from the XE-5000's FDA-cleared body fluid analysis applications.

"By standardizing instrument platforms, information integration, and advanced technologies, laboratories can achieve unparalleled levels of optimization for laboratory operations that literally transform their productivity - all of which offer the enormous benefit of standardized care and consistency," said Kershaw.

About BioReference Laboratories, Inc.

BRLI is the third largest full service laboratory in the United States and the largest independent laboratory in the Northeastern market, primarily a clinical testing lab servicing physician offices with concentrations in the focused markets of esoteric testing, molecular diagnostic, anatomical pathology and correctional health care. BRLI operates as a national oncology laboratory under its GenPath label. Better science, superior technology and better service have enabled GenPath to earn a reputation as one of the premier hematopathology laboratories in the country. GeneDx, a wholly owned subsidiary, is the BRLI genetics laboratory and is typically recognized as the leading laboratory for testing of rare genetic diseases; GeneDx has now become a technology leader with GenomeDx, based on a CGH array platform and its NextGen sequence offerings that are and will be disease specific.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leade
'/>"/>

SOURCE Sysmex America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
5. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
6. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
7. Mesa Laboratories Names New Vice President of Sales and Marketing
8. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
10. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
11. JDRF partners with Housey Pharmaceutical Research Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... (Nasdaq: BLUD ), a global leader in providing ... announced that Paul D. Mintz, M.D. has been appointed ... January 1, 2010. ,, Dr. Mintz has been ... than 30 years. He is a tenured Professor of ... of Medicine. He also serves as director of the ...
(Date:12/16/2009)... 16 For wounded U.S. servicemen ... in Washington, D.C., the holidays can be a particularly ... travel home rely more than ever on the healing ... week, calling home just got easier for Walter Reed ... cards, which will provide hundreds of minutes of holiday ...
(Date:12/16/2009)... -- HealthSciences Institute will sponsor a new ... and organizations who serve individuals at risk ... employer, health plan, medical home and other ... free, noncommercial webinars on topics, solutions and ... and care improvement. Each webinar will include ...
(Date:12/16/2009)... a role in reducing inflammation in the lungs , , ... that plays a role in inflammation seems to protect ... adults who smoke. , Researchers also found that adult ... a lower risk of developing chronic obstructive pulmonary disease ... , "The gene seems to be protective of the ...
(Date:12/16/2009)... GAINESVILLE, Fla. University of Florida researchers at work ... the first to predict the spread of the disease ... than 21 million calls to determine how often residents ... region composed of two islands off the coast of ... in recent years. Its government commissioned the study as ...
Breaking Medicine News(10 mins):Health News:Immucor Appoints New Board Director 2Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3
... - CRH Medical Corporation,(CRM:TSX-V) announced today that it ... Chicago. The new Clinic will be located west ... CRH,s overall,patient appointment capacity and expands accessibility to ... the Chicago expansion, Edward Wright CEO of CRH ...
... Oct. 10 Major financial implications are,at stake ... record,the health conditions of patients that are present ... Centers for Medicare and Medicaid,Services (CMS). CMS ... (DRG),assignment, including new methods for identifying patients who ...
... 10 Abbott has been named to,Hispanic Business ... Abbott was recognized as one of the magazine,s ... hiring, promotion, marketing,philanthropy and supplier diversity. "As ... of our,people to provide different ideas, perspectives and ...
... Web Cast Set for 11:00 a.m. EDT, POWAY, ... a leading provider of diagnostic imaging systems and,services to ... before the market opens on Thursday, October 25,2007, financial ... 30, 2007. A conference call is scheduled for ...
... Evaluation of ATIR by Dr. Velardi for ... Mismatched Bone Marrow Transplantation, AMSTERDAM, Netherlands, ... physician initiated European Phase II,clinical study for its lead product ... the successful treatment of,thirteen end stage blood cancer patients with ...
... against identity theft, but what about medical identity theft? ... danger if false entries in medical records lead to ... uses a person,s name and sometimes other parts of ... the person,s knowledge or consent to obtain medical services ...
Other Medicine News:Health News:CRH Medical Corporation opens second clinic in Chicago 2Health News:Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms 2Health News:Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms 3Health News:Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine 2Health News:Digirad Corporation to Release Third Quarter, Nine-Month Financial Results on October 25, 2007 2Health News:Kiadis Pharma Announces ATIR Interim Clinical Results 2Health News:Kiadis Pharma Announces ATIR Interim Clinical Results 3Health News:Medical identity theft: the importance of protecting your health records 2
(Date:12/16/2009)... AVAX Technologies, Inc. (Pink Sheets: AVXT) ... recently closed a bridge loan financing (the "2009 ... Purchase Agreement (the "Agreement") with Firebird Global Master ... Company sold a convertible promissory note, due June ... US$1,400,000, and issued a warrant to purchase an ...
(Date:12/16/2009)... 16 International, well-known,scientific experts ... GFT505 (80 mg/day),data presented as "extremely ... scientists and clinicians critically reviewed these ... of generic lipid-modifying,treatments, fenofibrate and bezafibrate, ... observed in patients with metabolic syndrome,and ...
(Date:12/16/2009)... Boston Scientific Corporation (NYSE: BSX ... has elected Nelda Connors as a Director. ... and Metal Products division of Tyco International. Previously, ... several positions in operations and general management. Prior ... of executive and management capacities with Ford, Chrysler and ...
Breaking Medicine Technology:AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 62784 1Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 62784 2Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 62784 3Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 62784 4Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 62784 5IgeaCare Solutions Inc Emerges Under New Leadership and Funding 11022 1IgeaCare Solutions Inc Emerges Under New Leadership and Funding 11022 2New approach to sickle cell disease shows promise in mice 62780 1New approach to sickle cell disease shows promise in mice 62780 2
... -, BRIDGEWATER, N.J., Sept. 18 Results ... study showed that 84 percent of,treatment-naive HIV-1 infected ... mg (two 400 mg tablets) with 100 mg ... reached an undetectable viral load (<50 copies/mL) at ...
... FOLD ) today announced that it plans to ... HCl) for Pompe Disease at the,American Society of Human ... CA. This plan was announced by John Crowley, President ... & Medtech 2007 Conference in London, United Kingdom. ...
Other Medicine Technology:New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 2New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 3New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 4New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 5New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 6New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 7Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease 2
There are many reasons to choose the CardioGenesis 2000 Holmium:YAG Laser System for TMR in your hospital or medical facility. Among the first is the CardioGenesis commitment to deliver the highest q...
Ultrasensitive TSH EIA Thyroid Function 025-BC-1003...
Total T3 EIA Thyroid Function 025-BC-1005...
... anti-TPO test kit is a solid phase ... It is designed for the quantitative measurement ... in serum or plasma. The microplate is ... controls and patient samples are pipetted into ...
Medicine Products: